Medacta Group SA (MEDGF)
OTC
Closed
Aug 24, 2026
Day's Range
160.0052 wk Range
83.91Overview - MEDGF - Medacta Group SA
Key Statistics
Valuation
Enterprise Value
3.98B
P/E (Trailing)
‪28.67‬
Price / Sales (TTM)
‪6.05‬
Price / Book
‪6.05‬
EV / EBITDA
‪19.87‬
Profitability
Profit Margin
‪13.96%‬
Operating Margin
‪15.96%‬
Return on Assets
‪8.39%‬
Return on Equity
‪22.83%‬
Ownership
Shares Outstanding
19.91M
Float
5.99M
Held by Insiders
‪69.66%‬
Held by Institutions
‪15.26%‬
Price stats
Beta
‪0.98‬
50-Day Avg
‪117.39‬
200-Day Avg
‪92.28‬
Dividends
Payout Ratio
‪15.48%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MEDGF - Medacta Group SA
Peers - MEDGF - Medacta Group SA
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
Profile Summary - MEDGF - Medacta Group SA
About
Medacta Group SA is a Swiss medical device company specializing in the development, manufacture, and distribution of orthopedic and neurosurgical products. Medacta Group SA focuses on solutions for hip, knee, shoulder, and spine procedures, supported by personalized 3D planning tools and surgical techniques used in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
